Source: Major League Baseball has not yet decided to discipline Biogenesis players

50 Comments

A source familiar with the Biogenesis investigation tells HardballTalk that Major League Baseball plans to interview all of the players implicated in the Biogenesis scandal by the end of June. Then, at that point, it will make a decision on whether to pursue discipline and how. The plan is for discipline to be leveled — if it is, indeed, leveled — by the first week of July.  Pursuant to the Joint Drug Agreement players will then have the right to appeal if discipline is imposed.

This information confirms ESPN’s Outside the Lines report from last night that Major League Baseball’s  investigation of Biogenesis is proceeding. However, any speculation that Major League Baseball has already decided to discipline the players implicated in the Biogenesis scandal or that it has already decided to impose any specific penalties, be they 50- or 100-game suspensions, was premature. The league’s investigation is being assisted by clinic founder Tony Bosch, the source confirmed.

When contacted by HardballTalk, Major League Baseball officials did not comment on the story.

Alex Rodriguez of the New York Yankees, 2011 NL MVP Ryan Braun of the Milwaukee Brewers and Melky Cabrera of the Toronto Blue Jays – who received a 50-game suspension last season for the use of PEDs – are among the 20 players reportedly being targeted by MLB.

Braun issued a stern denial this morning, while Cabrera told USA Today Sports: “I don’t know anything about it. This is the first I hear of it. If they suspend me again, I think that would be a harsh punishment because I already served my sentence. But it’s up to them.”

Rodriguez, once considered a threat to break the sport’s all-time home run record, admitted to ESPN four years ago that he used performance-enhancing drugs earlier in his career, when he played for the Texas Rangers.

Report: Steven Matz has been pitching through pain, may need elbow surgery

Mike Stobe/Getty Images
1 Comment

Newsday’s Marc Carig reports that Mets starter Steven Matz has been pitching through pain for most of the season. He may need surgery to fix a nerve issue in his elbow. Matz was sidelined in spring training with an elbow injury and made his regular season debut on June 10.

Matz, 26, has struggled over 13 starts, posting a 6.08 ERA with a 48/19 K/BB ratio in 66 2/3 innings. Many were scrambling for explanations for his pitching woes and now they have it.

According to Carig, the Mets let Matz skip his bullpen sessions to help him pitch through the pain. Given the Mets’ shoddy history of dealing with injuries, that’s not a good look for the club.

Carig noted on Twitter that Jacob deGrom offers some optimism for Matz’s case. deGrom underwent right elbow surgery to repair ulnar nerve damage last September and bounced back to have a great season this year.

Clayton Kershaw’s simulated game went so well he threw an extra inning

Denis Poroy/Getty Images
Leave a comment

Dodgers lefty Clayton Kershaw was scheduled to throw three innings in a simulated game on Monday. That simulated game went so well, he threw an extra inning, MLB.com’s Ken Gurnick reports. Kershaw will make a minor league rehab start next and could be activated towards the end of next week.

Kershaw, 29, has been on the disabled list since July 24 with a lower back strain. That put the pause button on another outstanding season. He’s carrying a 15-2 record with a 2.04 ERA and a 168/24 K/BB ratio in 141 1/3 innings.

The 87-35 Dodgers have run away with the NL West, needing some combination of 20 wins and 20 Rockies losses (19 for the third-place Diamondbacks) to officially clinch the division. While the Dodgers are all but mathematically assured of reaching postseason baseball, the club would still like to get Kershaw as ready as possible over the next month-plus.